Showing results (231-240 of 321) with videos related to
Sort By:
Pageof 33
British Journal of Cancer|January 13, 2006
Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndromeS E Bojesen, O Ammerpohl, A Weinhäusl, et al.HNO|February 16, 2006
[Influence of ischemia/hypoxia on the HIF-1 activity and expression of hypoxia-dependent genes in the cochlea of the newborn rat]B Mazurek, C Rheinländer, F-U Fuchs, et al.Pediatrics|May 1, 1976
Transcutaneous PO2 monitoring in routine management of infants and children with cardiorespiratory problemsR Huch, A Huch, M Albani, et al.Leukemia|June 2, 2007
Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphomaK Busch, T Keller, U Fuchs, et al.Minerva Cardioangiologica|December 15, 2006
Papillary fibroelastoma of the ascending aorta presenting with cardiogenic shockO Coskun, T Coskun, L Arusoglu, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 21, 2017
Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trialA Zittermann, J B Ernst, S Prokop, et al.Herz|January 24, 2014
[Heart and combined heart-lung transplantation. Indications, chances and risks]T Puehler, S Ensminger, U Schulz, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemiaU Fuchs, G Rehkamp, O A Haas, et al.Journal of Medicinal Chemistry|July 1, 1991
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinonesK D Hargrave, J R Proudfoot, K G Grozinger, et al.Nutrition Journal|August 25, 2017
Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trialJ B Ernst, S Prokop, U Fuchs, et al.Pageof 33